![](/img/cover-not-exists.png)
P501 Baseline characteristics of Crohn's disease patients in the vedolizumab PASS study: a cohort study assessing the safety and effectiveness of vedolizumab compared to other biologic agents (02)
Siegel, C.A., Lichtenstein, G., Siegmund, B., Lewis, J.D., Wolf, D., Louis, E., Sebastian, S., Hebuterne, X., Bell, A., Söderman, C., Schubert, S., Atreya, R., Polyak, S., Hoque, S., Krummenerl, A., BVolume:
11
Language:
english
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjx002.625
Date:
February, 2017
File:
PDF, 139 KB
english, 2017